Join us as Ed McDermott shares his journey of building EMMAC Life Sciences into CureLeaf International, navigating regulatory ambiguity across Europe, and the future of cannabis legalization and industry growth. This episode covers risk management, compliance, investment challenges, and the potential of cannabis as a medical and recreational product.
Key topics
Building EMAC Life Sciences into CureLeaf International
Navigating European cannabis regulations and cultural differences
Risks and challenges in early-stage cannabis ventures
The importance of compliance and cybersecurity in cannabis industry
Future outlook for cannabis legalization and industry growth
Guest name
Ed McDermott
Chapters
00:00 Introduction and Ed's Background
02:14 From a Blank Sheet to Europe's Cannabis Leader
03:53 First 18 Months: Challenges and Lessons
08:00 Team Formation and Cultural Dynamics
09:56 Medical Cannabis and Patient Impact
12:03 European Regulatory Framework and Cultural Nuances
15:13 Making Decisions in Ambiguous Regulatory Environments
19:52 Supply Chain Security and Cybersecurity Risks
25:05 Funding and Raising Capital in Cannabis
29:48 Compliance, Regulation, and Industry Challenges
39:50 Future Outlook: Rescheduling and Industry Growth
50:04 Legal and Criminal Market Dynamics
01:00:13 Lessons Learned and Advice for Entrepreneurs
01:05:12 The Purpose and Passion Behind Building a Business
01:08:03 Closing Remarks and Future Opportunities
